Gencom is leading innovation in the field of in-silico drug discovery optimization and advancing the current state of high performance computing for clients engaged in functional genomics and other computationally intensive drug discovery activities.

The company is tapping the power of scientific discovery and technological innovation to advance the practice of in-silico discovery in order to dramatically improve the quality of people's lives.

Our Discovery Process Optimization model includes the novel application of Microsoft technologies to problems of interest to science and society.